PathAI CEO Dr. Andrew Beck discusses how he went from a career as a physician scientist to the CEO of one of the most formative Pathology AI startups in Medicine. Hear the story of a pathologist who uses the catalyst of winning a premier AI pathology research competition to build the leading pathology AI company that's raised $255M from investors across the healthcare services and pharma industries including Polaris Partners, General Catalyst, Kaiser Permanente, Bristol Myers Squibb, Labcorp and Merck's Global Health Innovation Fund.